Logo (Actavis) 638 Pill: yellow, capsule/oblong, 16mm
The pill with imprint Logo (Actavis) 638 (Yellow, Capsule/Oblong, 16mm) has been identified as Lamotrigine Extended-Release 250 mg and is used for Bipolar Disorder, Lennox-Gastaut Syndrome, Seizure Prevention, Epilepsy, and Seizures. It belongs to the drug class triazine anticonvulsants and is not a controlled substance.
Images for Logo (Actavis) 638
Lamotrigine Extended-Release
- Imprint
- Logo (Actavis) 638
- Strength
- 250 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00228-1638
- Inactive Ingredients
-
hypromelloses,
lactose monohydrate,
magnesium stearate,
methacrylic acid - methyl methacrylate copolymer (1:2),
polyethylene glycol 400,
silicon dioxide,
magnesium silicate,
titanium dioxide,
triethyl citrate,
ferric oxide yellow,
ferric oxide red,
polydextrose,
copovidone,
ferrosoferric oxide
Note: Inactive ingredients may vary.
See also:
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,849)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
- Lamotrigine monograph
- Lamotrigine (FDA)
- Lamotrigine Chewable Tablet (FDA)
- Lamotrigine Extended Release Tablet (FDA)
- Lamotrigine ODT (FDA)
Other brands
Lamictal, Lamictal XR, Subvenite
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.